featured
2022 Top Story in Eye Care: Advances in the Intraocular Drug Delivery System
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Chang MA, Kapre A, Kaufman D, et al. Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial. JAMA Ophthalmol. 2022;140(8):771–778.
- Schaub F, Schiller P, Hoerster R, et al. Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial. Ophthalmology. 2022;129(10):1129–1141.
- Laich Y, Wolf J, Hajdu RI, et al. Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci. 2022;63(5):17.